Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) SystemsNCT07616206vTv TherapeuticsPhase 2Not yet recruiting2027-06Estimated
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored StudyNCT07620574ExelixisPhase 3Enrolling by invitation2030-05-31Estimated
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)NCT07621237Tonix Pharmaceuticals, Inc.Phase 2Recruiting2028-02Estimated
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )NCT07621718RVMDPhase 3Recruiting2028-12-30Estimated
Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation ResearchNCT07623668OculisPhase 3Recruiting2027-12Estimated
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IHNCT07625280Jazz PharmaceuticalsPhase 3Recruiting2027-12-23Estimated
Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard ChemoradiationNCT07628062IBRXPhase 2Not yet recruiting2030-12-31Estimated
Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)NCT07632898Inhibikase TherapeuticsPhase 3Not yet recruiting2030-06-30Estimated
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.NCT07635563Incannex Healthcare LtdPhase 2Recruiting2027-04Estimated
Open-Label Safety Study of AXS-14 in Subjects With FibromyalgiaNCT07637162AXSMPhase 3Enrolling by invitation2028-05Estimated
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)NCT07637734VRCAPhase 3Recruiting2027-05Estimated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerNCT07644559VSTMPhase 2Recruiting2027-06Estimated
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBDNCT07652294SYREPhase 2Enrolling by invitation2029-03-02Estimated
Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 VaccineNCT07655180IVVDPhase 3Recruiting2026-08Estimated
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)NCT07656415AGIOPhase 3Recruiting2029-08Estimated
A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk FactorsNCT07656727BIOAPhase 2Active not recruiting2026-11-30Estimated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung CancerNCT07659782VSTMPhase 2Recruiting2027-06Estimated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal CancerNCT07659795VSTMPhase 2Recruiting2027-06Estimated
Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)NCT07660094CADLPhase 3Recruiting2031-10-22Estimated
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) TabletsNCT07671911Trevi TherapeuticsPhase 3Recruiting2028-06Estimated
The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)NCT07671924Trevi TherapeuticsPhase 2Recruiting2027-09Estimated
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)NCT07673744TGTXPhase 2Recruiting2028-07-01Estimated
A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma StudyNCT07677059KYMRPhase 2Recruiting2028-12Estimated
CHAMPION: A Study to Evaluate the Efficacy and Safety of Obudanersen (ION582) in Children and Adults With Angelman Syndrome (AS)NCT07782827IONSPhase 3Recruiting2028-05Estimated
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis SuppurativaNCT07783542ORKAPhase 2Recruiting2028-10Estimated
NAI Plus Standard of Care Compared With Placebo Plus Standard of Care in Critically Ill Adults With SepsisNCT07783789IBRXPhase 2Not yet recruiting2028-05-12Estimated
Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP).NCT07838506OKYOPhase 3Not yet recruiting2027-05Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.